Novoderm Aps: Financial statements 2023
CVR: 42112747
Source: annual report 2023, Danish Business Authority
01/10/2022 – 30/09/2023
Novoderm Aps (CVR 42112747) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 1,167,698 and a net result of DKK 272,276 compared with DKK -329,396 the year before. That is an increase of 151.2% compared with the year before. Equity in the 2023 report amounted to DKK -531,939. The company had 2 employees in the financial year.
- Gross Profit
- DKK 1,167,698
- Profit/Loss
- DKK 272,276
- Equity
- DKK -531,939
- Total Assets
- DKK 558,044
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 1.2 mio. | 272 t. | -532 t. | 2 |
| 2022 | - | 465 t. | -329 t. | -755 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Novoderm Aps has published its annual report for 2022. Gross profit came to DKK 464,845, and the net result was DKK -329,396.
About Novoderm Aps
Novoderm Aps is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2021. The company is registered under the industry Speciallægers aktiviteter. The company was previously named Privatklinik Nomo Roskilde ApS. The management consists of Jeanette Svensson. The company is owned by Svensson Inc ApS. The company has 5 employees (2026). In 2025, the company reported a gross profit of DKK 2,045,973 and a net result of DKK 59,938 compared with DKK 152,554 the year before. Equity in the 2025 report amounted to DKK -668,845.